Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

3.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of ferroptosis-inducing R4VP compounds for targeting aggressive cancers.

Oncogene·2026
Same author

The landscape of the ubiquitin-proteasome system in cancer.

Cell death and differentiation·2026
Same author

Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer.

NPJ precision oncology·2026
Same author

Atmospheric Aging Alters the Toxicity Mechanisms of Residential Wood Combustion Aerosol: A Parallel <i>In Vivo</i> and <i>In Vitro</i> Study.

Environmental science & technology·2026
Same author

Single cell RNA sequencing reveals transitional states and signaling shifts in nephron progenitor cells of the late-gestation rhesus macaque kidney.

BMC genomics·2026
Same author

Proteomic analysis of horse hair extracts provides no evidence for the existence of a hypoallergenic Curly Horse breed.

Clinical and translational allergy·2026
Same journal

Structural proteomics reveals that misfolded nascent proteins expose buried lysines for ubiquitination and rapid proteasomal degradation.

Cell reports·2026
Same journal

Physical interactions within the SIR heterochromatin complex potentiate inter-subunit communication and gene repression.

Cell reports·2026
Same journal

An IGF2BP3-dependent metabolic circuit governs macrophage recruitment and immunosuppression in glioblastoma.

Cell reports·2026
Same journal

A cold-induced GDF15-secreting adipocyte subpopulation regulates energy homeostasis through endocrine signaling.

Cell reports·2026
Same journal

RelB drives integrin-mediated stress tolerance and relapse in high-grade serous ovarian cancer.

Cell reports·2026
Same journal

Yeast β-glucan supplementation supports immunometabolic anti-tumor responses and reverses obesity-induced dysfunction via trained hematopoiesis.

Cell reports·2026
See all related articles

Related Experiment Video

Updated: Mar 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

RNF4-Dependent Oncogene Activation by Protein Stabilization.

Jane J Thomas1, Mona Abed1, Julian Heuberger2

  • 1Rappaport Research Institute and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.

Cell Reports
|September 23, 2016
PubMed
Summary
This summary is machine-generated.

RNF4 ubiquitylation stabilizes key cancer-driving transcription factors, enhancing their activity and promoting tumor growth. This mechanism is crucial for cancer cell survival and linked to poor patient outcomes.

Keywords:
STUbLSUMOgene regulationoncogenesubiquitin

More Related Videos

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

891

Related Experiment Videos

Last Updated: Mar 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

891

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Ubiquitin Signaling

Background:

  • Ubiquitylation is a key regulator of signaling pathways in cancer, often targeting proteins for degradation.
  • Oncogenic transcription factors are typically short-lived, tightly controlling their activity.

Purpose of the Study:

  • To investigate the role of RNF4 in regulating oncogenic transcription factors.
  • To elucidate the mechanism by which RNF4 influences protein stability and transcriptional activity.

Main Methods:

  • Investigated ubiquitylation by RNF4 on specific oncogenic transcription factors (β-catenin, Myc, c-Jun, N-ICD).
  • Analyzed the impact of RNF4 on transcriptional activity and gene expression (Wnt, Notch pathways).
  • Examined the molecular requirements for RNF4-mediated stabilization, including phosphorylation, SUMOylation, and RNF4 domains.

Main Results:

  • RNF4 ubiquitylation stabilizes short-lived oncogenic transcription factors, enhancing their transcriptional activity.
  • Stabilization depends on substrate phosphorylation and RNF4 binding, not SUMOylation, and involves unique polyubiquitin chains and chromatin docking.
  • RNF4 promotes tumor phenotype and cancer cell survival, with elevated RNF4 correlating with poor patient survival and increased incidence in colon adenocarcinomas.

Conclusions:

  • RNF4-dependent ubiquitylation converts transient phosphorylation signals into sustained oncoprotein activation by stabilizing key transcription factors.
  • RNF4 represents a potential therapeutic target in cancers characterized by elevated RNF4 levels or activity.